PCI offers a broad range of services to address the manufacturing needs of our clients at each stage of the product lifecycle.
Central to PCI’s international service offering is our capability to manufacture a range of dosage forms in compliance with current GMP standards.
For over 30 years, we have been successfully manufacturing pharmaceutical dosage forms for our international client base. Our strength lies in the integrated nature of our services, combining formulation development and analytical services with clinical trial manufacturing for both potent and non-potent molecules. This comprehensive yet flexible package is delivered with close coordination of each stage of the development process by our experienced project management team. Our facilities have been designed to allow flexibility in processing technology and are
approved for the manufacture of investigational and commercial products. From a handful of capsules for first in-man studies to hundreds of kilogrammes of tablets, we have the technology and capacity to satisfy your clinical trial needs whatever the phase of development.
By combining formulation and analytical testing with GMP clinical trial manufacturing and packaging, we are able to offer a seamless service throughout your development journey.
Potent and non-potent Clinical supplies include:
- Small manual batches
- API into capsules using Xcelodose® technology
- Large-scale batches through fully automated technology
Contained Xcelodose® Technology
Recent investments in fully contained Xcelodose® 600S technology continues to demonstrate our market leading position and continued commitment to delivering best in class solutions for potent molecules.
Utilizing our state-of-the-art facilities, PCI has an unrivaled capability to produce solid oral dose forms containing highly potent active pharmaceutical ingredients for both investigational and commercial use.